Funding of US$14.5 million was secured by NSG BioLabs, a biotech co-working laboratory and office space supplier located in Singapore.
Investors
- Celadon Partners
- ClavystBio
Use of funds
The firm plans to promote the growth of its co-working laboratory and office spaces in addition to enhancing its infrastructure, services, and resident perks.
Abput NSC BioLabs
Under the direction of CEO and Founder Daphne Teo, NSG BioLabs supports life sciences enterprises with equipment, capital efficiency, effective operations, team skills, and worldwide networks. The R&D environment is located in Singapore’s prestigious Biopolis and spans 35,000 square feet. It includes fully functional, accredited BSL-2 laboratory and office infrastructure.
With a focus on precision medicine, nucleic acids, AI-enabled drug discovery, synthetic biology, and agrifood, the firm has been supporting innovators in the health, biomedical, and industrial biotechnology sectors since 2019. More than 40 businesses have benefited from its services as residents; among them, the startups have reached important business milestones and secured almost US$400M in capital.
“We look forward to further empowering our residents in their innovation efforts through expanded facilities, enhanced value-add offerings, and greater exposure to valuable industry networking and mentorship experiences. We are thankful for the recognition from our strategic investors, Celadon Partners and ClavystBio.”
Daphne Tea
